AlphaMadera's AlphaVal page classifies Zions Bancorporation, National Association as a Banks, Insurers & Asset Managers business and values it using P/Tangible Book × ROE Quality, then compares the result to the current market price to flag ZION as undervalued, fairly valued, or overvalued.

What is Zions Bancorporation, National Association's fair value?

Fair value for ZION comes from a P/Tangible Book × ROE Quality model -- the approach AlphaVal selected for this company's Banks, Insurers & Asset Managers classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value ZION?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. ZION was classified as Banks, Insurers & Asset Managers and is valued using P/Tangible Book × ROE Quality, built from ZION's most recent reported fundamentals.

ZION - Zions Bancorporation, National Association

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $75.33 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate

Trading 35.6% below fair value

Current Price $63.37

Bear Case $68.90 8.7% upside ($68.90 - $63.37) / $63.37 = 8.7% ROTCE 11.1% → 1.45x TBV

Fair Value $98.43 55.3% upside ($98.43 - $63.37) / $63.37 = 55.3% ROTCE 14.8% → 2.21x TBV

Bull Case $127.96 101.9% upside ($127.96 - $63.37) / $63.37 = 101.9% ROTCE 17.0% → 2.66x TBV

Adjust Assumptions

Return on Tangible Equity

14.8%

Cost of Equity

8.9%

Key Value Driver

ROTCE (14.8%) vs. cost of equity (8.9%)

Terminal Value % of EV

Implied Market Multiple 1.52x

Market is pricing in (growth)

Plain-Language Summary

With ROTCE of 14.8% vs. 8.9% cost of equity, fair P/TBV is 2.21x on $41.72 tangible book, implying $98.43 per share. DDM cross-check: $34.44.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (51 analysts) $75.33

Analyst Range $67.00 – $84.00

Divergence from AlphaVal 31%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.

⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

ℹ Dividend-based valuation: $34.44 (65% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

ℹ Wall Street's average price target is $75.33 (from 51 analysts). Our estimate is 31% above the consensus -- consider that gap carefully.

Key Risks

Book value quality matters as much as level — check loan loss reserves
Interest rate sensitivity creates non-linear earnings surprises
Insurance reserving is actuarial, not financial — errors emerge slowly